| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $70K | +0.0% |
| R&D Expense | $1.9M | +254.3% |
| SG&A Expense | $4.1M | +203.5% |
| Operating Income | -$5.9M | -230.3% |
| Pre-tax Income | -$5.9M | -193.6% |
| Income Tax | $42K | +0.0% |
| Net Income | -$5.9M | -187.5% |
| EPS (Basic) | -$0.89 | -169.7% |
| EPS (Diluted) | -$0.89 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.7M | — |
| Current Assets | $10.8M | +791.6% |
| Total Assets | $13.0M | +266.3% |
| Current Liabilities | $1.3M | -44.8% |
| Total Liabilities | $2.6M | -33.7% |
| Stockholders' Equity | $10.4M | +2811.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.5M | -620.3% |
| Capital Expenditures | $396K | +37.3% |
| Investing Cash Flow | -$359K | -15.4% |
| Financing Cash Flow | $18.5M | +1751.8% |
| Free Cash Flow | -$8.9M | -505.8% |
| -169.7% |